Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Sales (2016 - 2025)

Historic Return on Sales for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 0.34%.

  • Ekso Bionics Holdings' Return on Sales rose 3200.0% to 0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.6% for FY2024, which is 2400.0% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Return on Sales of 0.34% as of Q3 2025, which was up 3200.0% from 1.96% recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Return on Sales peaked at 0.34% during Q3 2025, and registered a low of 1.96% during Q2 2025.
  • Moreover, its 5-year median value for Return on Sales was 0.98% (2022), whereas its average is 1.02%.
  • In the last 5 years, Ekso Bionics Holdings' Return on Sales skyrocketed by 16400bps in 2021 and then plummeted by -14800bps in 2025.
  • Ekso Bionics Holdings' Return on Sales (Quarter) stood at 1.13% in 2021, then fell by -13bps to 1.27% in 2022, then skyrocketed by 43bps to 0.73% in 2023, then soared by 38bps to 0.45% in 2024, then rose by 25bps to 0.34% in 2025.
  • Its last three reported values are 0.34% in Q3 2025, 1.96% for Q2 2025, and 1.04% during Q1 2025.